These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20415602)

  • 61. Special delivery: targeted therapy with small RNAs.
    Peer D; Lieberman J
    Gene Ther; 2011 Dec; 18(12):1127-33. PubMed ID: 21490679
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A daunting task: manipulating leukocyte function with RNAi.
    Peer D
    Immunol Rev; 2013 May; 253(1):185-97. PubMed ID: 23550647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.
    Li T; Wu M; Zhu YY; Chen J; Chen L
    Nucleic Acid Ther; 2014 Aug; 24(4):302-12. PubMed ID: 24796432
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current concepts and management of glioblastoma.
    Preusser M; de Ribaupierre S; Wöhrer A; Erridge SC; Hegi M; Weller M; Stupp R
    Ann Neurol; 2011 Jul; 70(1):9-21. PubMed ID: 21786296
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.
    Nikaki A; Piperi C; Papavassiliou AG
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1475-88. PubMed ID: 22809292
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy.
    Yan R; Hallam A; Stockley PG; Boyes J
    Biochem J; 2014 Jul; 461(1):1-13. PubMed ID: 24927119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The potential RNAi-based combination therapeutics.
    Jung HS; Shin YK
    Arch Pharm Res; 2011 Jan; 34(1):1-2. PubMed ID: 21468909
    [No Abstract]   [Full Text] [Related]  

  • 68. RNAi-based drug discovery and its application to therapeutics.
    Hokaiwado N; Takeshita F; Banas A; Ochiya T
    IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The current state and future directions of RNAi-based therapeutics.
    Setten RL; Rossi JJ; Han SP
    Nat Rev Drug Discov; 2019 Jun; 18(6):421-446. PubMed ID: 30846871
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RNAi therapeutics and applications of microRNAs in cancer treatment.
    Uchino K; Ochiya T; Takeshita F
    Jpn J Clin Oncol; 2013 Jun; 43(6):596-607. PubMed ID: 23592885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge.
    Colombo S; Zeng X; Ragelle H; Foged C
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1481-95. PubMed ID: 24950005
    [TBL] [Abstract][Full Text] [Related]  

  • 72. From RNA interference technology to effective therapy: how far have we come and how far to go?
    Keaney J; Campbell M; Humphries P
    Ther Deliv; 2011 Nov; 2(11):1395-406. PubMed ID: 22826872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
    Grimm D; Kay MA
    J Clin Invest; 2007 Dec; 117(12):3633-41. PubMed ID: 18060021
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel RNA interference-based therapies for sepsis.
    Kosovrasti VY; Lukashev D; Nechev LV; Amiji MM
    Expert Opin Biol Ther; 2014 Apr; 14(4):419-35. PubMed ID: 24397825
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of new RNAi therapeutics.
    Liu G; Wong-Staal F; Li QX
    Histol Histopathol; 2007 Feb; 22(2):211-7. PubMed ID: 17149694
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic delivery of small RNA using lipid nanoparticles.
    Asai T; Oku N
    Biol Pharm Bull; 2014; 37(2):201-5. PubMed ID: 24492716
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Electrotransfer of RNAi-based oligonucleotides for oncology.
    Chabot S; Pelofy S; Paganin-Gioanni A; Teissie J; Golzio M
    Anticancer Res; 2011 Dec; 31(12):4083-9. PubMed ID: 22199265
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RNAi-based therapeutics-current status, challenges and prospects.
    Tiemann K; Rossi JJ
    EMBO Mol Med; 2009 Jun; 1(3):142-51. PubMed ID: 20049714
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clostridial translocation peptides for promoting endosomal escape of RNAi agents (WO09083738).
    Lundin P
    Expert Opin Ther Pat; 2010 Jul; 20(7):975-80. PubMed ID: 20497045
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Promising human brain tumors therapy with interference RNA intervention (iRNAi).
    Rolle K; Nowak S; Wyszko E; Nowak M; Zukiel R; Piestrzeniewicz R; Gawronska I; Barciszewska MZ; Barciszewski J
    Cancer Biol Ther; 2010 Mar; 9(5):396-406. PubMed ID: 20118657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.